Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Nelonemdaz by GNT Pharma for Acute Ischemic Stroke: Likelihood of Approval
Nelonemdaz is under clinical development by GNT Pharma and currently in Phase I for Acute Ischemic Stroke. According to GlobalData,...